21 May 2024
On May 15, Professor Danny Soon, CEO of the Consortium for Clinical Research and Innovation, Singapore (CRIS), along with his team, visited the Shanghai headquarters of Taimei Technology.
During the visit, Professor Danny Soon, CEO of Consortium for Clinical Research and Innovation, Singapore (CRIS), toured Taimei Technology’s Digital Clinical Research Exhibition Hall, gaining insight into the company’s operations and innovative culture. Professor Soon and Taimei’s Chairman and CEO, Mr. Zhao Lu, along with senior executives, held discussions focused on future collaboration in clinical research.
This visit marks a significant step in Taimei’s commitment to expanding global partnerships in clinical research. We look forward to establishing a strong, long-term collaboration with CRIS to advance multinational clinical research initiatives.
Professor Soon will also deliver a keynote address at the 2024 DIA Drug Information Conference, titled “The Clinical Trial Ecosystem in Singapore,” highlighting the unique advantages of conducting clinical trials in Singapore.
